Oric Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Heyman Richard A. | — | Sale | 3,215 | $25.31 | $81,372 | 223,885 | May 17, 2021 |
| SCHELLER RICHARD H | — | Sale | 500 | $25.06 | $12,530 | 43,882 | May 14, 2021 |
| Heyman Richard A. | — | Sale | 100 | $25.11 | $2,511 | 227,100 | May 11, 2021 |
| SCHELLER RICHARD H | — | Sale | 100 | $25.00 | $2,500 | 48,997 | May 11, 2021 |
| Chacko Jacob | President and CEO | Sale | 400 | $25.02 | $10,008 | 58,910 | May 11, 2021 |
| SCHELLER RICHARD H | — | Sale | 200 | $25.11 | $5,022 | 49,600 | Apr 30, 2021 |
| Chacko Jacob | President and CEO | Sale | 700 | $25.06 | $17,542 | 61,000 | Apr 30, 2021 |
| Heyman Richard A. | — | Sale | 100 | $25.26 | $2,526 | 227,200 | Apr 28, 2021 |
| SCHELLER RICHARD H | — | Sale | 200 | $25.00 | $5,000 | 49,800 | Apr 1, 2021 |
| Heyman Richard A. | — | Sale | 100 | $25.00 | $2,500 | 227,400 | Apr 1, 2021 |
| Chacko Jacob | President and CEO | Sale | 800 | $25.09 | $20,072 | 61,700 | Apr 1, 2021 |
| GORDON CARL L | — | Sale | 27,869 | $23.93 | $666,905 | 2,212,571 | Mar 29, 2021 |
| ORBIMED ADVISORS LLC | — | Sale | 27,869 | $23.93 | $666,905 | 2,212,571 | Mar 29, 2021 |
| ORBIMED ADVISORS LLC | — | Sale | 32,959 | $24.80 | $817,383 | 2,395,334 | Mar 26, 2021 |
| GORDON CARL L | — | Sale | 27,816 | $23.88 | $664,246 | 2,315,995 | Mar 25, 2021 |
| GORDON CARL L | — | Sale | 3,992 | $24.32 | $97,085 | 2,428,293 | Mar 19, 2021 |
| OrbiMed Capital GP VI LLC | — | Sale | 7,673 | $26.47 | $203,104 | 2,432,285 | Mar 19, 2021 |
| GORDON CARL L | — | Sale | 18,790 | $28.43 | $534,200 | 2,467,292 | Mar 18, 2021 |
| OrbiMed Capital GP VI LLC | — | Sale | 18,790 | $28.43 | $534,200 | 2,467,292 | Mar 16, 2021 |
| ORBIMED ADVISORS LLC | — | Sale | 90,521 | $30.29 | $2,741,881 | 2,616,645 | Mar 11, 2021 |
| GORDON CARL L | — | Sale | 90,521 | $30.29 | $2,741,881 | 2,616,645 | Mar 11, 2021 |
| LG Management, LLC | — | Sale | 2,268,750 | — | — | 1,100,446 | Nov 4, 2020 |
| Chacko Jacob | President and CEO | C | 62,500 | — | — | 62,500 | Apr 28, 2020 |
| GORDON CARL L | — | C | 236,111 | — | — | 2,765,717 | Apr 28, 2020 |
| COLUMN GROUP II, LP | — | C | 416,666 | — | — | 4,616,666 | Apr 28, 2020 |
| ORBIMED ADVISORS LLC | — | C | 236,111 | — | — | 2,765,717 | Apr 28, 2020 |
| LG Management, LLC | — | C | 231,250 | — | — | 231,250 | Apr 28, 2020 |
| Svennilson Peter | — | C | 3,500,000 | — | — | 3,575,000 | Apr 28, 2020 |
| SCHELLER RICHARD H | — | C | 25,000 | — | — | 50,000 | Apr 28, 2020 |
| Heyman Richard A. | — | C | 62,500 | — | — | 227,500 | Apr 28, 2020 |